AML with FLT-3 mutation is treated by :: (A) Crizotinib, (B) Gilteritinib, (C) Acalabrutinib, (D) Ibrutinib
Answer is B. Gilteritinib inhibits FMS like tyrosine Kinase 3 (FLT-3) and hence used in the treatment of AML with FLT-3 mutation.